Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Lower vitamin D levels might be linked to more severe alopecia areata, but more research is needed to understand if vitamin D can help treat it.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Alopecia areata patients experience more psychological distress, linked to certain neurotrophin levels.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

The enzyme for activating vitamin D is found in many body tissues, not just the kidneys.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

The document concludes that an inherited nail condition often improves on its own, and spironolactone effectively treats acne in women.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Fat, bone, and the brain are interconnected in regulating energy and health.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Combining platelet-rich plasma and hyaluronic acid effectively reduces pain and improves function in TMJ disorders.

The dressing helps heal chronic wounds by swelling and releasing drugs when needed.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Bicalutamide shows promise for treating female hair loss.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Vitamin C derivative reduces hair loss-related protein in cells.

Higher IL-21 levels may help predict alopecia areata activity.